IRIS
RADAELLI, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.652
AS - Asia 2.210
NA - Nord America 1.661
SA - Sud America 527
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.575
RU - Federazione Russa 1.457
SG - Singapore 855
CN - Cina 709
BR - Brasile 454
SE - Svezia 308
RO - Romania 266
HK - Hong Kong 227
VN - Vietnam 206
IT - Italia 143
FR - Francia 120
DE - Germania 109
GB - Regno Unito 78
IN - India 42
CA - Canada 36
FI - Finlandia 35
NL - Olanda 33
BD - Bangladesh 31
AR - Argentina 29
MX - Messico 28
JP - Giappone 23
PL - Polonia 22
ZA - Sudafrica 21
TR - Turchia 18
ID - Indonesia 17
IE - Irlanda 17
IR - Iran 17
EC - Ecuador 16
ES - Italia 14
IQ - Iraq 12
AT - Austria 10
CO - Colombia 8
UA - Ucraina 8
SA - Arabia Saudita 7
UZ - Uzbekistan 7
PK - Pakistan 6
CH - Svizzera 5
CL - Cile 5
JO - Giordania 5
LT - Lituania 5
MD - Moldavia 5
MY - Malesia 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
NI - Nicaragua 4
PH - Filippine 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JM - Giamaica 3
PE - Perù 3
UY - Uruguay 3
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 7.089
Salva come PNG Salva come JPEG
Città #
Singapore 354
Dallas 304
Moscow 278
Hong Kong 224
San Jose 212
Ashburn 181
Hefei 103
Shanghai 103
Lauterbourg 88
Beijing 86
Ho Chi Minh City 84
Lawrence 72
Princeton 72
New York 68
Munich 64
Los Angeles 53
São Paulo 44
Milan 43
Hanoi 37
Boardman 34
Orem 31
Warsaw 19
Denver 18
Manchester 18
Helsinki 17
Dublin 16
Tokyo 16
Montreal 15
Rome 15
Chennai 14
Johannesburg 14
Rio de Janeiro 14
Turku 14
Amsterdam 13
Chicago 13
Da Nang 13
Guangzhou 13
Mexico City 13
Ankara 12
London 12
Seattle 12
Brooklyn 11
Houston 11
Mumbai 11
Phoenix 11
Poplar 11
Santa Clara 11
Atlanta 10
Brasília 10
Haiphong 10
Nuremberg 10
Stockholm 10
The Dalles 10
Frankfurt am Main 9
Vienna 9
Baghdad 8
Barnet 8
Dronten 8
Tehran 8
Tianjin 8
Toronto 8
Ribeirão Preto 7
Tashkent 7
Washington 7
Pune 6
Amman 5
Belo Horizonte 5
Bergamo 5
Campinas 5
City of London 5
Duque de Caxias 5
Jacksonville 5
Medellín 5
Osasco 5
Piscataway 5
Porto Alegre 5
Querétaro 5
Quito 5
Shenzhen 5
Zurich 5
Aracaju 4
Buenos Aires 4
Cesano Boscone 4
Changsha 4
Charlotte 4
Cotia 4
Curitiba 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Hangzhou 4
Izmir 4
Kuala Lumpur 4
Lappeenranta 4
Miami 4
Paris 4
Salvador 4
San Francisco 4
Santa Fe 4
Secaucus 4
Totale 3.200
Salva come PNG Salva come JPEG
Nome #
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 352
Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations 175
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 170
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 130
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 120
Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography 115
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 110
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene 108
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 105
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 102
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 100
Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica 98
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis 97
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 95
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 95
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients 92
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 91
the multiple sclerosis knowledge Questionnaire: a self administered instrument of recently diagnosed patients 90
Dysregulation of MS risk genes and pathways at distinct stages of disease 86
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO) 86
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis 85
Brain and cord imaging features in neuromyelitis optica spectrum disorders 83
Application of deep-learning to NMOSD and unclassified seronegative patients 82
Breastfeeding is not related to postpartum relapses in multiple sclerosis 79
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 78
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 76
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 74
Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis 74
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 74
Clinical and MRI predictors of response to interferon‐beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients 72
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 70
Critical role for prokineticin 2 in CNS autoimmunity 69
Experience of an information aid for newly diagnosed multiple sclerosis patients: A qualitative study on the SIMS-Trial 69
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 68
THIOTEPA-CYCLOPHOSPHAMIDE HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AGGRESSIVE FORMS OF MULTIPLE SCLEROSIS: RESULTS IN 9 PATIENTS 67
Artificial Intelligence on Conventional Magnetic Resonance Images for the Diagnosis of Neuromyelitis Optica Spectrum Disorders 67
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD 66
Are Recurrent Myelitis a Prodromic Phase of Inflammatory Diseases or a Distinct Inflammatory Condition? 66
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 66
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach 65
Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. 64
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: An Italian multicenter study 64
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 64
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: A post-marketing observational study 63
Brain and Spinal Cord Imaging Features in Neuromyelitis Optica Spectrum Disorders 63
Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation in aggressive forms of multiple sclerosis: results in 9 patients 62
Forceps minor damage and co-occurence of depression and fatigue in multiple sclerosis 62
Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder 62
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis. 61
Natalizumab treatment after autologous haematopoietic stem cell transplantation in patients with aggressive multiple sclerosis 61
Efficacy and safety of nabiximols (Sativex (R)) on multiple sclerosis spasticity in a real-life Italian monocentric study 59
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 59
Mitoxantrone: benefits and risks in multiple sclerosis patients 58
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report 58
MGAT5 and disease severity in progressive multiple sclerosis 58
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis 58
Evolving concepts in the treatment of relapsing multiple sclerosis 58
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks. 58
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 58
Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study 58
Optical coherence tomography and visual-evoked potentials: which is more sensitive in multiple sclerosis? 57
Neuromyelitis optica spectrum disorders: Long-term safety and efficacy of rituximab in Caucasian patients 57
Evoked potentials scores: a useful tool in monitoring and predicting the course of multiple sclerosis? 56
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. 56
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results 56
Sars-CoV2 infection in pregnant women with multiple sclerosis 55
Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment 55
Disclosing the diagnosis of multiple sclerosis: The Profile Project 55
Multiple sclerosis progression is not associated with birth timing in Italy 54
Evoked Potential Abnormalities Predict Disability Progression at 5 Years in Patients with CIS 54
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 54
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood 54
Practice of yoga may cause damage of bothsciaticnerves: a case report 53
White Matter Myelin Alterations are Diffuse in Neuromyelitis Optica Spectrum Disorders and Prevail on Axonal Damage 52
Neuromyelitis optica: Concepts in evolution 52
Recurrence of disease activity after repeated Natalizumab withdrawals. 51
Regional gray matter atrophy is largely unrelated to white matter tissue loss in relapsing remitting multiple sclerosis. 51
Oral corticosteroids for multiple sclerosis relapse 51
Global and regional hippocampal volumes are preserved in neuromyelitis optica spectrum disorders and do not contribute to cognitive impairment 50
Stem Cell-Based Therapies, Remyelination, and Repair Promotion in the Treatment of Multiple Sclerosis 50
Signs and symptoms of COVID-19 in patients with multiple sclerosis 50
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. 50
White matter myelin alterations are diffuse in Neuromyelitis Optica spectrum disorders and prevail on axonal damage 50
Differential diagnosis of optic neuritis in neuromyelites optica and multiple sclerosis: are VEPs useful? 49
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. 49
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial. 48
Evoked potential abnormalities predict disability progression at 5 years in patients with CIS 48
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. 46
Golbal and Regional Hippocampal Volumes Are Preserved In Neuromyelitis Optica and Do not Seem to Be Related to Cognitive Impairment 45
NMO spectrum disorder and optic neuritis: are VEPs useful? 45
Spinal cord atrophy in neuromyelitis optica is spatially associated to spinal cord lesions and clinical disability 45
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression 44
Hippocampal regional vulnerability to damage differs between MS and neuromyelitis optica 44
Hippocampal Regional Vulnerability to Damage Differs Between MS and Neuromyelitis Optica 42
White matter myelin alterations are diffuse in Neuromyelitis Optica Spectrum Disorders and prevail on axonal damage 42
Revealing structural and clinical heterogeneity in the spectrum of neuromyelitis optica with unsupervised machine learning 41
Global and regional hippocampal volumes are preserved in neuromyelitis optica spectrum disorders and do not seem to be related to cognitive impairment 40
Mr t2-relaxation time as an indirect measure of brain water accumulation in neuromyelitis optica spectrum disorders 39
Revealing structural and clinical heterogeneity in the spectrum of neuromyelitis optica with unsupervised machine learning 39
Hippocampal Regional Vulnerability to Damage Differs Between MS and Neuromyelitis Optica 39
Totale 7.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 30 1 2 1 3 2 3 0 2
2022/2023504 182 129 55 2 5 60 19 15 19 6 9 3
2023/2024229 7 26 22 26 27 42 4 20 0 7 10 38
2024/20251.593 130 14 20 59 69 85 434 102 262 131 121 166
2025/20264.737 339 376 378 679 350 187 357 314 1.291 263 112 91
2026/202728 28 0 0 0 0 0 0 0 0 0 0 0
Totale 7.189